nialamide has been researched along with Vitiligo in 1 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Local injection of physostigmine revealed that dermatomally distributed vitiligo was associated with a dysfunction of the sympathetic nerves in the affected skin and that non-dermatomally distributed vitiligo was not." | 3.65 | Vitiligo: a new classification and therapy. ( Koga, M, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koga, M | 1 |
1 other study available for nialamide and Vitiligo
| Article | Year |
|---|---|
Vitiligo: a new classification and therapy.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Female; Humans; Male; Middle Aged; Nialamide; Physostigm | 1977 |